Condition: Intensive Care Unit (ICU) Admission · Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
The goal of this randomized clinical trial is to determine whether a biomarker-signature (BV) supported antibiotic treatment decision matrix can have a beneficial impact on antibiotic use and patient outcomes in an ICU population.
This description comes directly from the study's public registry record.
Makeda Semret, MD · 15149341934 · makeda.semret@mcgill.ca
Always discuss trial participation with your own doctor first.
| Montreal General Hospital | Montreal, Quebec, Canada | Recruiting |
| Research Institute of McGill University Health Center (RI-MUHC) | Montreal, Quebec, Canada | Recruiting |
| Royal Victoria Hospital | Montreal, Quebec, Canada | Recruiting |
| Research Institute McGill University Health Centre | Montreal, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07481773